| abstract |
Formulations suitable for the treatment of diseases associated with undesirable expression or activity of IL-13 are provided. The present invention relates to formulations for storing anti-IL-13 antibodies. These preparations are effective as pharmaceuticals, for example. Thus, in one aspect, the invention provides (a) an anti-IL-13 antibody, (b) an anti-freezing agent, and (c) a buffer such that the pH of the formulation is about 5.5-6.5. The present invention relates to an anti-IL-13 antibody preparation comprising In another aspect, the invention relates to a pharmaceutical composition for the treatment of IL-13 related diseases. The pharmaceutical composition includes an anti-IL-13 antibody formulation described herein, eg, a formulation comprising a humanized antibody, and other features described herein. |